News & Stories


Cooper Implants First Drug-Eluting Stent for PVD in New Jersey

Cooper Vascular Surgeons implanted the First Drug Eluting stent for the treatment of Peripheral Vascular Disease (PVD) in the State of New Jersey.

Restenosis is a process of stent failure, which is the Achilles heel of long term stent success. A recent study showed a 50 percent reduction in the amount of restenosis using the drug coated PTX stent.

Peripheral vascular disease is a common circulatory problem, affecting more than 10 million people in the United States, in which narrowed arteries reduce blood flow to limbs, usually in the legs.